Aptus Pharma Limited (BOM:544529)
492.50
-4.50 (-0.91%)
At close: Nov 16, 2026
| Market Cap | 8.45B +710.0% |
| Revenue (ttm) | 811.18M +178.0% |
| Net Income | 79.50M +124.5% |
| EPS | 4.66 +131.4% |
| Shares Out | 17.15M |
| PE Ratio | 105.60 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,200 |
| Open | 504.50 |
| Previous Close | 497.00 |
| Day's Range | 492.50 - 506.00 |
| 52-Week Range | 57.20 - 510.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 20, 2026 |